Fred Alger Management »

Cytokinetics shares owned by Fred Alger Management

Quarter-by-quarter ownership of Cytokinetics (CYTK) shares owned by Fred Alger Management from 13F filings

Historical chart of Fred Alger Management investment in Cytokinetics

Tip: Access up to 7 years of quarterly data

All positions including Cytokinetics held by Fred Alger Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytokinetics by Fred Alger Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.7M 21k 83.49

More positions owned by Fred Alger Management

Microsoft Corp Common (MSFT)
Amazon Common (AMZN)
Apple Common (AAPL)
Nvidia Corp. Common (NVDA)
Meta Platforms Inc Class A Common (META)
Alphabet Inc Cl C Common (GOOG)
Natera Common (NTRA)
Visa Inc Class A Shares Common (V)
Mercadolibre Common (MELI)
Transdigm Group Common (TDG)
Adobe Common (ADBE)
Marvell Technology Group Common (MRVL)
Gfl Environmental Common (GFL)
Pinterest Inc Class A Common (PINS)
Advanced Micro Devices Common (AMD)

View all positions for Fred Alger Management

Top funds holding Cytokinetics

Vanguard Group
Wellington Management Company
Caption Management
T. Rowe Price Associates
Henderson Group
Boxer Capital
Citadel Advisors
Partner Fund Management
Logos Global Management
Lord, Abbett & Co
Millennium Management
Artal Group
Barclays
Gts Securities
Goldman Sachs Group

View all funds holding Cytokinetics